Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2003-12-03
Original market date: See footnote 1
1996-12-31
Product name:
VIVELLE 100MCG
DIN:
02204444 Electronic product monograph is not available
Company:
NOVARTIS PHARMACEUTICALS CANADA INC
100
700 Rue Saint-Hubert
Montreal
Quebec
Canada
H2Y 0C1
Class:
Human
Dosage form(s):
Patch
Route(s) of administration:
Transdermal
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:16.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03CA03 ESTRADIOL
Active ingredient group (AIG) number:See footnote5
0106457010
Active ingredient(s) See footnote8 | Strength |
---|---|
ESTRADIOL | 8.66 MG |